Shamszadeh Sayna, Eghbal Mohammad Jafar, Asgary Saeed
Iranian Center for Endodontic Research, Research Institute of Dental Sciences, Shahid Beheshti University of Medical Science Tehran, Iran.
Am J Stem Cells. 2024 Jun 15;13(3):132-142. doi: 10.62347/BYPG4014. eCollection 2024.
This systematic review evaluates clinical studies investigating regenerative endodontic procedures for mature/immature teeth utilizing stem cell transplantation. An electronic search of Scopus, PubMed, ISI Web Science, and Google Scholar was conducted up to January 2023. Outcome measures encompassed radiographic (periapical lesion, root length, apical foramen width, volume of the regenerated pulp) and clinical (post-operative pain, sensibility test) parameters. Among 3250 identified articles, five clinical studies were selected, comprising two randomized controlled trials (RCTs) for mature/immature teeth, and three case reports/series for mature teeth. Despite the promising potential, the included studies exhibited a notable risk of bias. The diversity in stem cells (e.g., dental pulp stem cells [DPSCs], umbilical cord mesenchymal stem cells [UC-MSCs]), scaffolds (Atecollagen, collagen membrane, platelet-poor plasma [PPP], leukocyte platelet-rich in fibrin [L-PRF]), and growth factors (granulocyte colony-stimulating factor [G-CSF]) emphasized the heterogeneity across interventions. In RCTs, DPSCs application increased root length and reduced apical foramen width in immature teeth, while UC-MSCs transplantation reduced apical lesions in mature teeth. Transplantation of DPSCs aggregates or UC-MSCs/PPP also elicited positive pulp responses and increased blood flow. In case reports/series, DPSCs application in teeth with irreversible pulpitis resulted in mineralization and increased the regenerated pulp' volume. Furthermore, transplantation of DPSCs with G-CSF/atelocollagen or L-PRF/collagen membrane led to positive pulp responses. While underscoring the potential of stem cell transplantation for regenerative endodontics in mature/immature teeth, the overall evidence quality and the limited number of available studies emphasize the need for cautious interpretation of results. Future well-designed clinical studies are essential to validate these findings further.
本系统评价评估了利用干细胞移植对成熟/未成熟牙齿进行再生牙髓治疗的临床研究。截至2023年1月,对Scopus、PubMed、ISI Web of Science和谷歌学术进行了电子检索。结果指标包括影像学参数(根尖周病变、牙根长度、根尖孔宽度、再生牙髓体积)和临床参数(术后疼痛、感觉测试)。在3250篇检索到的文章中,选取了5项临床研究,其中包括2项针对成熟/未成熟牙齿的随机对照试验(RCT)和3项针对成熟牙齿的病例报告/系列研究。尽管具有潜在的前景,但纳入的研究存在明显的偏倚风险。干细胞(如牙髓干细胞[DPSC]、脐带间充质干细胞[UC-MSC])、支架材料(脱细胞胶原、胶原膜、贫血小板血浆[PPP]、富含纤维蛋白的富白细胞血小板[L-PRF])和生长因子(粒细胞集落刺激因子[G-CSF])的多样性突出了不同干预措施之间的异质性。在随机对照试验中,应用牙髓干细胞增加了未成熟牙齿的牙根长度并减小了根尖孔宽度,而移植脐带间充质干细胞减少了成熟牙齿的根尖病变。移植牙髓干细胞聚集体或脐带间充质干细胞/贫血小板血浆也引发了积极的牙髓反应并增加了血流量。在病例报告/系列研究中,将牙髓干细胞应用于患有不可复性牙髓炎的牙齿导致了矿化并增加了再生牙髓的体积。此外,将牙髓干细胞与粒细胞集落刺激因子/脱细胞胶原或富含纤维蛋白的富白细胞血小板/胶原膜一起移植也产生了积极的牙髓反应。虽然强调了干细胞移植在成熟/未成熟牙齿再生牙髓治疗中的潜力,但总体证据质量和现有研究数量有限强调了对结果进行谨慎解读的必要性。未来设计良好的临床研究对于进一步验证这些发现至关重要。